Dr. John Michael Ristuccia is a Fairhaven, Massachusetts based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He does not accept the Medicare-approved amount. Patients will be billed for the treatment. Active license number of Dr. John Michael Ristuccia is 11590 for Oral and Maxillofacial Surgery in Massachusetts. His current practice location is 46 Balsam St, Fairhaven. Patients can reach him at 508-999-6098.
Dr. John Michael Ristuccia deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. John Michael Ristuccia speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1023173788
NPI Enumeration Date:
23 Dec, 2006
NPI Last Update On:
21 Oct, 2015
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. John Michael Ristuccia are as mentioned below.
License Number
Specialization
State
Status
11590
Oral and Maxillofacial Surgery
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
46 Balsam St, Fairhaven, Massachusetts
Zip:
02719-7045
Phone Number:
508-999-6098
Patients can reach Dr. John Michael Ristuccia at 46 Balsam St, Fairhaven, Massachusetts or can call to book an appointment on 508-999-6098. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.